Virosil Pharma: Curating Eco-Friendly Disinfection Solutions That Are Safe To Use

Dev Gupta, CEO

Dev Gupta

CEO

The market for contamination control solutions in India is experiencing robust growth due to increasing awareness of health and safety standards across various sectors. As industries expand and hygiene regulations tighten, the demand for advanced disinfectants and fumigants rises significantly. These solutions play a crucial role by providing effective products that prevent the spread of harmful microorganisms. Their innovations ensure safe environments in healthcare, industrial, and commercial settings, contributing to public health and operational efficiency.

Virosil Pharma is a groundbreaking, eco-friendly, and nontoxic disinfectant and fumigant designed to meet the stringent sterilization needs of industries such as pharmaceuticals, vaccines, life sciences, nutraceuticals, ayurvedic, tissue culture and research labs. Manufactured in India with swiss technology, the product is endorsed by global health authorities, including the USFDA and European healthcare agencies. This chlorine-free, non-mutagenic formulation effectively eliminates airborne bacteria and fungi in sterile environments like injectable and formulation manufacturing areas within just 60 minutes. Its ULV fogger produces a fine mist that ensures complete disinfection without the need for rinsing, making it ideal for critical surfaces, instruments, and packaging in pharmaceutical production.

In an exclusive interview with Pharma Industry Outlook, Dev Gupta, CEO enlightens us more about Virosil Pharma.

What are the key benefits of Virosil Pharma as a disinfectant in pharmaceutical and healthcare environments?

Virosil Pharma is a versatile, non-toxic disinfectant ideal for aerial fumigation, surface, instrument, and DM plant disinfection. A 20 percent concentration fumigates 1,000 cubic feet within 60 minutes using a ULV fogger, while a 5 percent solution ensures sterile floors, walls, and equipment. It effectively eliminates microbial loads in DM plants, AHU systems, and storage tanks, replacing formaldehyde fumigation with safer, eco-friendly practices. The product is also widely used for disinfecting air handling units, pipelines, and critical surfaces in pharmaceutical environments, ensuring a pathogen-free setting. Its colorless, odorless and biodegradable properties make it a superior choice for maintaining sterile conditions.

Virosil has undergone extensive testing by renowned institutions in India, confirming its efficacy in disinfection and fumigation for the pharmaceutical and healthcare industries. Notable institutions include Haffkine Institute, Indian Drug Laboratory, Italab Pvt. Ltd. and KEM Hospital, which validated its effectiveness against various pathogens and in surface disinfection. Certifications include FDA Drug License, ISO, Halal, WHO-GMP and Efficacy Validation Reports.

Virosil Pharma is a groundbreaking, eco-friendly, and non-toxic disinfectant and fumigant designed to meet the stringent sterilization needs across industries

Dev Gupta, CEO

How does the Virosil formulation's combination of hydrogen peroxide and silver ions enhance its effectiveness as a disinfectant, and what makes it a safer alternative to traditional sterilization methods like formaldehyde?

The proprietary Virosil formula combines the disinfectant power of hydrogen peroxide with antimicrobial silver ions, creating a broad-spectrum solution that effectively eliminates bacteria, viruses, fungi, and spores. With a shelf life of two years, the product offers one of the longestlasting disinfectants available. The formula works by disrupting the cell walls of microorganisms with nascent oxygen, while silver ions enhance the effect by deactivating essential cellular functions. This combination ensures rapid microbial death and prevents re-germination. Eco-friendly and non-toxic, the product is highly effective across various applications, offering potent, long-lasting protection without harmful residues or fumes.

Virosil Pharma’s patented formulation, endorsed by leading pharmaceutical companies and hospitals worldwide, offers rapid and thorough sterilization without the harmful effects of traditional formaldehyde. When used with the recommended Sanomist fogger, it generates an ultra-fine mist that effectively penetrates cracks, sterilizing 1,000 cubic feet in just 60 minutes. The product is versatile, and suitable for air, surface, and water disinfection, making it ideal for areas such as Air Handling Units (AHUs), ducts, and storage tanks. With no harmful residues, it decomposes into water and oxygen, eliminating the need for de-fumigation. Approved by global regulatory authorities, it is a safer alternative to carcinogenic formaldehyde, ensuring a sterile and safe environment, trusted by leading pharmaceutical companies like Pfizer, Serum Institute of India, Biocon, Aurobindo, Eugia, Dabur, Jubliant, Glenmark, Lupin, Cipla, and Dr. Reddy’s.

How does Virosil, when used with the SanoMist Fogger Machine, enhance HVAC disinfection, and what are its key advantages over traditional formaldehyde-based methods?

Virosil provides exceptional cold sterilization, targeting all forms of viruses, bacteria, fungi, molds, and algae, including the Coronavirus. With features such as non-mutagenic properties, no foul odor, and no need for rinsing, the product ensures 100 percent elimination of airborne bacteria and fungi without irritating the eyes or requiring de-fumigation.

HVAC systems, crucial for heating, ventilation, and cooling, often harbor airborne particles that can lead to disease transmission. Therefore, maintaining their cleanliness is vital. Virosil, in conjunction with the SanoMist Fogger Machine, offers an advanced solution for disinfecting HVAC systems and AHU units. This combination generates a fine mist, enhancing the disinfectant's coverage and effectiveness.

Virosil Pharma surpasses traditional formaldehydebased methods by providing a safer, eco-friendly alternative. Proven effective against a wide range of pathogens, the product is used across industries, including pharmaceuticals and healthcare, ensuring a sterile environment with minimal environmental impact.

How do Virosil’s cold sterilization and non-toxic properties improve disinfection in healthcare settings, and what benefits does it offer in safety and efficiency?

Fogging, cleaning, and disinfecting critical surfaces and medical equipment are crucial for preventing the spread of harmful microorganisms in healthcare settings. I believe Virosil plays a vital role in this process. It effectively cleans critical hospital areas, disinfects operating theaters using a ULV fogger, sanitizes laundry and linen and treats HVAC systems. Safe for personnel, the product decomposes into water and oxygen, eliminating the need for post-fogging residue removal and reducing turnaround time. Its cold sterilization, non-toxic profile, and versatility make it ideal for hospitals, pharmaceutical warehouses, agro-based facilities, and e-Commerce environments, meeting diverse disinfection needs efficiently and safely.

How has Virosil Pharma’s eco-friendly and versatile approach set a new standard in disinfection?

Virosil Pharma has revolutionized the industry with its ecofriendly approach and versatile applications. Its solutions address contamination issues across air, surfaces, and water, offering superior effectiveness compared to traditional disinfectants. This innovative approach has set a new standard, making the product a leader in solving critical contamination challenges and providing the industry with a reliable and sustainable solution for maintaining optimal hygiene and safety.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.